|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000138771 |
Summary for SHROOM3 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000138771 | Gene symbol | SHROOM3 |
| Gene name | shroom family member 3 | |
| HGNC | 30422 | |
| Entrez ID | 57619 | |
| Gene type | protein_coding | |
| Synonyms | SHROOM3|ShrmL|SHRM|KIAA1481|APXL3 | |
| UniProtAcc | Q8TF72 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for SHROOM3 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| SHROOM3 | 1.13e+04 | -1.44e+00 | 5.33e-01 | -2.71e+00 | 6.82e-03 | 2.81e-02 | ESCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| SHROOM3 | 4.81e+03 | -1.12e+00 | 1.38e-01 | -8.05e+00 | 8.04e-16 | 8.69e-15 | COAD |
Top |
Sex-biased somatic mutation for SHROOM3 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for SHROOM3 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg19162496 | chr4:76435022 | CGI:chr4:76420857-76421554 | promoter | 2.81e-01 | 1.77e-01 | 2.89e+00 | 3.79e-03 | 1.82e-02 | 1.04e-01 |
| BRCA | cg14898892 | chr4:76435027 | CGI:chr4:76420857-76421554 | promoter | 3.67e-01 | 2.12e-01 | 2.27e+00 | 2.29e-02 | 3.69e-02 | 1.55e-01 |
| KIRP | cg14898892 | chr4:76435027 | CGI:chr4:76420857-76421554 | promoter | 6.91e-01 | 7.98e-01 | -2.96e+00 | 3.09e-03 | 1.02e-02 | -1.07e-01 |
| KICH | cg05951609 | chr4:76435354 | CGI:chr4:76420857-76421554 | UTR,promoter,exon,gene body | 9.47e-02 | 1.99e-01 | -2.52e+00 | 1.18e-02 | 2.95e-02 | -1.04e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg05951609 | chr4:76435354 | CGI:chr4:76420857-76421554 | UTR,promoter,exon,gene body | 3.93e-01 | 2.91e-01 | 2.22e+00 | 2.61e-02 | 2.80e-02 | 1.03e-01 |
| LUSC | cg24086068 | chr4:76434855 | CGI:chr4:76420857-76421554 | promoter | 3.13e-01 | 5.28e-01 | -2.03e+00 | 4.23e-02 | 4.36e-02 | -2.15e-01 |
| BLCA | cg20311846 | chr4:76435097 | CGI:chr4:76420857-76421554 | promoter | 1.45e-01 | 2.65e-01 | -3.60e+00 | 3.22e-04 | 9.47e-04 | -1.20e-01 |
| LIHC | cg20311846 | chr4:76435097 | CGI:chr4:76420857-76421554 | promoter | 4.14e-01 | 3.13e-01 | 2.87e+00 | 4.08e-03 | 5.51e-03 | 1.01e-01 |
| LIHC | cg27417997 | chr4:76435263 | CGI:chr4:76420857-76421554 | UTR,promoter,exon,gene body | 7.38e-01 | 6.37e-01 | 5.19e+00 | 2.09e-07 | 9.80e-07 | 1.01e-01 |
| LIHC | cg05951609 | chr4:76435354 | CGI:chr4:76420857-76421554 | UTR,promoter,exon,gene body | 6.08e-01 | 4.82e-01 | 3.87e+00 | 1.10e-04 | 2.25e-04 | 1.26e-01 |
| ESCA | cg05951609 | chr4:76435354 | CGI:chr4:76420857-76421554 | UTR,promoter,exon,gene body | 2.32e-01 | 1.14e-01 | 2.00e+00 | 4.60e-02 | 4.84e-02 | 1.18e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg24086068 | chr4:76434855 | CGI:chr4:76420857-76421554 | promoter | 2.65e-01 | 5.38e-01 | -3.46e+00 | 5.39e-04 | 7.34e-04 | -2.74e-01 |
| BRCA | cg14898892 | chr4:76435027 | CGI:chr4:76420857-76421554 | promoter | 3.67e-01 | 5.65e-01 | -7.83e+00 | 5.07e-15 | 1.85e-14 | -1.98e-01 |
| KIRC | cg20311846 | chr4:76435097 | CGI:chr4:76420857-76421554 | promoter | 2.40e-01 | 1.10e-01 | 2.81e+00 | 5.03e-03 | 1.10e-02 | 1.31e-01 |
| HNSC | cg14898892 | chr4:76435027 | CGI:chr4:76420857-76421554 | promoter | 4.66e-01 | 3.02e-01 | 2.44e+00 | 1.46e-02 | 2.29e-02 | 1.64e-01 |
| HNSC | cg27417997 | chr4:76435263 | CGI:chr4:76420857-76421554 | UTR,promoter,exon,gene body | 3.30e-01 | 2.00e-01 | 2.23e+00 | 2.59e-02 | 3.23e-02 | 1.30e-01 |
| COAD | cg14898892 | chr4:76435027 | CGI:chr4:76420857-76421554 | promoter | 7.08e-01 | 8.54e-01 | -2.06e+00 | 3.92e-02 | 4.20e-02 | -1.46e-01 |
| BLCA | cg19999035 | chr4:76434664 | CGI:chr4:76420857-76421554 | promoter | 5.80e-01 | 7.82e-01 | 2.19e+00 | 2.84e-02 | 3.41e-02 | -2.02e-01 |
Top |
Exon skipping events with PSI in TCGA for SHROOM3 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for SHROOM3 |
| ∗Please access CAeditome for RNA editing annotation. |
| Landscape of RNA editing events across multiple cancer types. |
 |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| ESCA | SHROOM3-012 | chr4_76633234_+ | 2.46e-01 | 1.49e-01 | 2.60e+00 | 9.45e-03 | 2.02e-02 | 9.68e-02 |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for SHROOM3 |
| TFs related to SHROOM3. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | ZNF418 | SHROOM3 | 4.42e+00 | 9.91e-01 | 2.34e+00 | 7.57e-04 | Male-biased |
| BRCA | ZNF79 | SHROOM3 | 4.31e+00 | 9.83e-01 | 2.95e+00 | 6.52e-03 | Male-biased |
| CHOL | LHX2 | SHROOM3 | 3.60e+00 | 9.46e-03 | 4.54e+00 | 9.85e-01 | Female-biased |
| CHOL | MSX1 | SHROOM3 | 2.96e+00 | 6.70e-03 | 3.98e+00 | 9.80e-01 | Female-biased |
| MESO | FOXA1 | SHROOM3 | 2.47e+00 | 3.04e-03 | 4.08e+00 | 9.84e-01 | Female-biased |
| MESO | FOXG1 | SHROOM3 | 2.20e+00 | 2.00e-03 | 3.92e+00 | 9.82e-01 | Female-biased |
| MESO | FOXR2 | SHROOM3 | 2.01e+00 | 1.08e-03 | 3.89e+00 | 9.82e-01 | Female-biased |
| MESO | MSX1 | SHROOM3 | 2.89e+00 | 6.35e-03 | 4.29e+00 | 9.84e-01 | Female-biased |
| MESO | NKX6-1 | SHROOM3 | 2.27e+00 | 2.19e-03 | 3.97e+00 | 9.83e-01 | Female-biased |
| MESO | POU6F2 | SHROOM3 | 3.22e+00 | 1.11e-02 | 4.45e+00 | 9.81e-01 | Female-biased |
| MESO | ZKSCAN2 | SHROOM3 | 2.68e+00 | 5.15e-03 | 4.14e+00 | 9.83e-01 | Female-biased |
| MESO | ZNF25 | SHROOM3 | 2.06e+00 | 1.44e-03 | 3.87e+00 | 9.81e-01 | Female-biased |
| MESO | ZNF33B | SHROOM3 | 2.64e+00 | 5.02e-03 | 4.11e+00 | 9.82e-01 | Female-biased |
| MESO | ZNF35 | SHROOM3 | 2.56e+00 | 2.97e-03 | 4.18e+00 | 9.86e-01 | Female-biased |
| MESO | ZNF418 | SHROOM3 | 1.36e+00 | 2.69e-05 | 4.18e+00 | 9.89e-01 | Female-biased |
| MESO | ZNF79 | SHROOM3 | 1.99e+00 | 4.04e-04 | 4.13e+00 | 9.88e-01 | Female-biased |
| SHROOM3 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for SHROOM3 |
| RBPs related to ES in SHROOM3. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| COAD | ESRP2 | exon_skip_424533 | 8.22e+00 | 7.43e-03 | 8.57e+00 | 9.86e-01 | Female-biased |
| CHOL | YBX2 | exon_skip_424544 | 1.17e+01 | 9.95e-01 | 1.11e+01 | 3.76e-03 | Male-biased |
| BRCA | YBX2 | exon_skip_424544 | 1.15e+01 | 9.82e-01 | 1.10e+01 | 1.68e-02 | Male-biased |
| KICH | YBX2 | exon_skip_424544 | 1.13e+01 | 4.50e-03 | 1.17e+01 | 9.95e-01 | Female-biased |
| SHROOM3 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs10026125 | chr4:75504304:C:G | - | 0.0330376064335283 | 0.0397978963296799 | LUAD | Female-baised eQTL |
| rs1841933 | chr4:75477348:G:A | - | 0.032423714825318 | 0.0499083846348408 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1828825 | chr4:70274245:C:T | - | 0.0712726273521471 | 0.00741688418260859 | HNSC | Male-baised eQTL |
| rs72663281 | chr4:76857360:A:G | - | 0.137529206551873 | 0.0124880655388552 | KIRP | Male-baised eQTL |
| rs62301074 | chr4:76853992:T:C | - | 0.136902494699056 | 0.0136750225547748 | KIRP | Male-baised eQTL |
| rs7693122 | chr4:76863143:T:A | - | 0.0898293261559897 | 0.0452349106750361 | KIRP | Male-baised eQTL |
| rs963857 | chr4:81003942:C:A | - | -0.083401893278526 | 0.0406123453372616 | LIHC | Male-baised eQTL |
| rs3846350 | chr4:82635847:A:G | - | -0.136975214045228 | 0.00144839590988375 | BLCA | Male-baised eQTL |
| rs6535368 | chr4:82645737:T:C | - | -0.136467968491114 | 0.0015627959687258 | BLCA | Male-baised eQTL |
| rs4693467 | chr4:82626350:T:C | - | -0.131884825925111 | 0.00246107037086982 | BLCA | Male-baised eQTL |
| rs7673383 | chr4:82627000:G:A | - | -0.131884825925111 | 0.00246107037086982 | BLCA | Male-baised eQTL |
| rs4693469 | chr4:82628611:A:C | - | -0.131795436836446 | 0.00250255356092913 | BLCA | Male-baised eQTL |
| rs906152 | chr4:82648414:G:C | - | -0.131265764472404 | 0.00270757135954393 | BLCA | Male-baised eQTL |
| rs6831105 | chr4:82656651:C:T | - | -0.125049514044309 | 0.00371152246015789 | BLCA | Male-baised eQTL |
| rs6819516 | chr4:82657574:T:C | - | -0.12603121744126 | 0.00460863607894976 | BLCA | Male-baised eQTL |
| rs4693476 | chr4:82652041:A:G | - | -0.125527098428754 | 0.00491157421257843 | BLCA | Male-baised eQTL |
| rs1568931 | chr4:82653154:C:A | - | -0.125527098428754 | 0.00491157421257843 | BLCA | Male-baised eQTL |
| rs10019352 | chr4:82653756:G:A | - | -0.125527098428754 | 0.00491157421257843 | BLCA | Male-baised eQTL |
| rs6822383 | chr4:82655480:G:A | - | -0.125527098428754 | 0.00491157421257843 | BLCA | Male-baised eQTL |
| rs6830953 | chr4:82664509:T:C | - | -0.123950939335663 | 0.00511808167812941 | BLCA | Male-baised eQTL |
| rs13148104 | chr4:82693897:T:C | - | -0.106473680522861 | 0.0150158200306265 | BLCA | Male-baised eQTL |
| rs2202570 | chr4:82665161:A:G | - | -0.104364185801999 | 0.0283581068011074 | BLCA | Male-baised eQTL |
| rs4693480 | chr4:82668505:A:G | - | -0.104364185801999 | 0.0283581068011074 | BLCA | Male-baised eQTL |
| rs1608942 | chr4:82671389:A:G | - | -0.104364185801999 | 0.0283581068011074 | BLCA | Male-baised eQTL |
| rs4693482 | chr4:82673899:A:G | - | -0.104364185801999 | 0.0283581068011074 | BLCA | Male-baised eQTL |
| rs76102569 | chr4:79974477:C:T | - | 0.166569167225346 | 0.00241143648129302 | LUAD | Male-baised eQTL |
| rs138736215 | chr4:75166090:C:T | - | 0.1522394753058 | 0.00829976897825499 | LUAD | Male-baised eQTL |
| rs34469188 | chr4:75167877:G:A | - | 0.1522394753058 | 0.00829976897825499 | LUAD | Male-baised eQTL |
| rs34815715 | chr4:75179316:T:C | - | 0.1522394753058 | 0.00829976897825499 | LUAD | Male-baised eQTL |
| rs62316905 | chr4:75194368:C:T | - | 0.1522394753058 | 0.00829976897825499 | LUAD | Male-baised eQTL |
| rs13126635 | chr4:75207765:T:G | - | 0.1522394753058 | 0.00829976897825499 | LUAD | Male-baised eQTL |
| rs151252257 | chr4:75217629:T:C | - | 0.1522394753058 | 0.00829976897825499 | LUAD | Male-baised eQTL |
| rs13140394 | chr4:75232263:T:G | - | 0.1522394753058 | 0.00829976897825499 | LUAD | Male-baised eQTL |
| rs34531386 | chr4:75217176:G:A | - | 0.15029088627323 | 0.00861824133055783 | LUAD | Male-baised eQTL |
| rs35592442 | chr4:75296026:C:T | - | 0.174516901762551 | 0.025732760247885 | LUAD | Male-baised eQTL |
| rs7356447 | chr4:79178950:G:A | - | -0.101489708348733 | 0.0267961563440767 | LUAD | Male-baised eQTL |
| rs787370 | chr4:67045686:G:T | - | -0.123725098182988 | 0.0352955102978479 | LUAD | Male-baised eQTL |
| rs10018724 | chr4:81841131:T:A | - | 0.0636025025857734 | 0.0107325219241739 | COAD | Male-baised eQTL |
| rs524737 | chr4:81842917:A:C | - | 0.0634150073882007 | 0.0133235567172856 | COAD | Male-baised eQTL |
| rs523017 | chr4:81843083:A:G | - | 0.0634150073882007 | 0.0133235567172856 | COAD | Male-baised eQTL |
| rs522875 | chr4:81843133:T:C | - | 0.0634150073882007 | 0.0133235567172856 | COAD | Male-baised eQTL |
| rs600754 | chr4:81843290:C:A | - | 0.0634150073882007 | 0.0133235567172856 | COAD | Male-baised eQTL |
| rs547188 | chr4:81844228:A:G | - | 0.0634150073882007 | 0.0133235567172856 | COAD | Male-baised eQTL |
| rs572255 | chr4:81843741:A:G | - | 0.0632658668215798 | 0.0137331828487458 | COAD | Male-baised eQTL |
| rs598543 | chr4:81843772:G:A | - | 0.0632658668215798 | 0.0137331828487458 | COAD | Male-baised eQTL |
| rs660505 | chr4:81845757:C:T | - | 0.0621660490143276 | 0.0178164370601347 | COAD | Male-baised eQTL |
| rs658862 | chr4:81846093:C:T | - | 0.0621660490143276 | 0.0178164370601347 | COAD | Male-baised eQTL |
| rs508846 | chr4:81846110:T:C | - | 0.0621660490143276 | 0.0178164370601347 | COAD | Male-baised eQTL |
| rs647540 | chr4:81846290:G:A | - | 0.0621660490143276 | 0.0178164370601347 | COAD | Male-baised eQTL |
| rs545073 | chr4:81859914:T:C | - | 0.0620298315986788 | 0.0183020412051554 | COAD | Male-baised eQTL |
| rs667443 | chr4:81858739:T:C | - | 0.059792561898716 | 0.0281420354856443 | COAD | Male-baised eQTL |
| rs637408 | chr4:81860870:T:G | - | 0.0580559394716136 | 0.0389048745316531 | COAD | Male-baised eQTL |
| rs660076 | chr4:81845835:T:A | - | 0.0565415328162912 | 0.0458279403370312 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000138771 |
| CpG Site: cg27466235 | |
| Position to Gene: gene | |
| Male Effect: -0.241241111646434 | |
| Female Effect: - | |
 | Gene ID: ENSG00000138771 |
| CpG Site: cg11615509 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.21482822485527 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg27466235 | chr4:76703942 | gene | -0.241241111646434 | 8.54109190652643e-05 | -0.3288355825034693 | 5.077361472202228e-07 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg11615509 | chr4:76607435 | gene | -0.21482822485527 | 8.44633598140875e-07 | -0.3573928077825612 | 4.248426059255118e-09 | LUAD |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of SHROOM3 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
